184 related articles for article (PubMed ID: 32354795)
21. Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors.
Miyagi E; Maruyama Y; Mogami T; Numazaki R; Ikeda A; Yamamoto H; Hirahara F
Int J Clin Oncol; 2017 Feb; 22(1):118-125. PubMed ID: 27623814
[TBL] [Abstract][Full Text] [Related]
22. High serum follistatin levels in women with ovarian endometriosis.
Florio P; Reis FM; Torres PB; Calonaci F; Abrao MS; Nascimento LL; Franchini M; Cianferoni L; Petraglia F
Hum Reprod; 2009 Oct; 24(10):2600-6. PubMed ID: 19549703
[TBL] [Abstract][Full Text] [Related]
23. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?
Anastasi E; Manganaro L; Granato T; Benedetti Panici P; Frati L; Porpora MG
Dis Markers; 2013; 35(5):331-5. PubMed ID: 24191126
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis.
Chen L; Wang X; Shu J; Xu S; Wu Q; Yu Y
Int J Gynaecol Obstet; 2019 Nov; 147(2):212-218. PubMed ID: 31469423
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
Chen JM; Gao HY; Wang Q; Li Q
Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
[TBL] [Abstract][Full Text] [Related]
26. High CA-125 and CA19-9 levels in spontaneous ruptured ovarian endometriomas.
Dai X; Jin C; Hu Y; Zhang Q; Yan X; Zhu F; Lin F
Clin Chim Acta; 2015 Oct; 450():362-5. PubMed ID: 26403090
[TBL] [Abstract][Full Text] [Related]
27. Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease.
Zheng H; Gao Y
Int J Gynecol Cancer; 2012 Jul; 22(6):1000-5. PubMed ID: 22426406
[TBL] [Abstract][Full Text] [Related]
28. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.
Cho HY; Kyung MS
Med Sci Monit; 2014 Jul; 20():1334-9. PubMed ID: 25073801
[TBL] [Abstract][Full Text] [Related]
29. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
[TBL] [Abstract][Full Text] [Related]
30. CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis.
Cho HY; Kyung MS
Med Sci Monit; 2019 Feb; 25():1087-1092. PubMed ID: 30737365
[TBL] [Abstract][Full Text] [Related]
31. The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer.
Nakamura N; Terai Y; Nunode M; Kokunai K; Konishi H; Taga S; Nakamura M; Yoo M; Hayashi M; Yamashita Y; Ohmichi M
J Ovarian Res; 2020 May; 13(1):51. PubMed ID: 32359364
[TBL] [Abstract][Full Text] [Related]
32. Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
Zhang W; Wang L; Xin Z
Medicine (Baltimore); 2018 Apr; 97(16):e0358. PubMed ID: 29668586
[TBL] [Abstract][Full Text] [Related]
33. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age.
Kondalsamy-Chennakesavan S; Hackethal A; Bowtell D; ; Obermair A
Gynecol Oncol; 2013 Jun; 129(3):467-71. PubMed ID: 23500084
[TBL] [Abstract][Full Text] [Related]
34. Endometriomas with low-risk malignancy potential in ultrasonography with high human epididymis protein 4 and risk of ovarian malignancy algorithm: a cases series.
Karacan T; Ozyurek E; Yesiralioglu S; Kiyak H; Usta T; Oral E
Gynecol Endocrinol; 2020 Feb; 36(2):117-121. PubMed ID: 31429337
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of CEA, SLX and CA125 in active pulmonary tuberculosis].
Ichiki H; Shishido M; Nishitani K; Takatsugi K; Nishiyama S; Yano M; Watanabe K
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1522-7. PubMed ID: 7907156
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women.
Nikolova T; Zivadinovic R; Evtimovska N; Klisarovska V; Stanojevic M; Georgievska J; Nikolova N
J Obstet Gynaecol Res; 2017 Dec; 43(12):1870-1879. PubMed ID: 29027715
[TBL] [Abstract][Full Text] [Related]
37. CA125 and HE4: Measurement Tools for Ovarian Cancer.
Zhao T; Hu W
Gynecol Obstet Invest; 2016; 81(5):430-5. PubMed ID: 27160726
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts.
Ant Ö; Özakşit G; Güzel Aİ; Cavkaytar S; Kaba M; Topçu HO
Taiwan J Obstet Gynecol; 2015 Jun; 54(3):236-9. PubMed ID: 26166333
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
[TBL] [Abstract][Full Text] [Related]
40. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
